Cysview Blue Light Cystoscopy for Detection of Bladder Cancer

Contact Information

Contact UW Carbone Cancer Center for appointment scheduling, patient referrals and more information: 

(608) 262-5223

(800) 622-8922

The UW Prostate and Genitourinary Cancer Program (UWPGCP) and the University of Wisconsin Carbone Cancer Center, the state's only comprehensive cancer center, take a multidisciplinary approach to treating bladder cancer.


Cysview Blue Light Cystoscopy

UW Health bladder cancer physicians offer Cysview, an optical imaging agent used during cystoscopy, for use in the detection of non-muscle papillary cancer of the bladder. Cysview can be used with patients for whom cancerous lesions are suspected or have been identified in previous cystoscopy procedures.


What is a Cystoscopy?


During cystoscopy, a thin tube with a camera (cystoscope) is inserted into the bladder through the urethra to view the suspicious area. The cystoscope can also be used to take a tissue sample for biopsy and to treat superficial tumors without surgery. We recommend cystoscopy be combined with other tests listed below for the most accurate diagnosis possible.


The Cysview Procedure

Cysview blue light cystoscopy is performed in two parts: conventional white light and blue light. The Cysview agent is introduced to the bladder, which is examined in white and blue light. Tumor cells stand out during the procedure, while healthy bladder tissue does not.


Advantages of Cysview



A conventional cystoscopy may provide unclear results under certain circumstances. Clinical trials demonstrate that Cysview cystoscopy improves detection of papillary bladder cancer, leading to a more complete treatment of bladder cancer.
Cysview also decreases the recurrence rate of subsequent cancers because it finds the smaller, "silent" tumors that may be missed previously with the standard view.